StockGuild

$COCP Short Articles Published Drowned out by FACTS PPS Rises

做多
NASDAQ:COCP   Cocrystal Pharma, Inc.
03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock.

sec.report/Document/...a20-11569_2sc13g.htm

To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:

In the Coronavirus Market: $COCP is to Treatment what $IBIO is to Vaccines or what $OPK is to Testing.

$COCP has completed all the financing and funding needed with two public offerings recently and are now aggressively pursing the development of Novel Anitiviral Compounds for treatment of any Corona infections including COVID-19

They have exclusive patent rights to the treatment and are in the process of advancing it quickly through a preclinical trial program.

Shorts will continue to write articles to downplay these facts as much as possible because the stock has a HUGE short position

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。